iPepGen: a modular, immunopeptidogenomic analysis pipeline for discovery, verification, and prioritization of cancer peptide neoantigen candidates.

Genome Biol · 2026 · PMC13040755 · PMID 41742304

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

These peptides were supported by high FragPipe PSM score probabilities (≥ 0.95) and deemed confident by PepQuery2 verification with highly significant p -values (≤ 1.0E-03).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.